New pill showdown: can roflumilast beat methotrexate for psoriasis in private areas?
Disease control
Not yet recruiting
This study tests two oral medications—roflumilast and methotrexate—for psoriasis in skin folds and genital areas, which are often hard to treat with creams alone. Fifty-six adults with topical-resistant psoriasis will take one of the two pills for 16 weeks. Researchers will measu…
Phase: PHASE2 • Sponsor: Eman Raafat Said • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC